Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network... Show more
The RSI Indicator for IKNA moved into overbought territory on July 28, 2025. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
The Momentum Indicator moved above the 0 level on July 25, 2025. You may want to consider a long position or call options on IKNA as a result. In of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for IKNA just turned positive on July 25, 2025. Looking at past instances where IKNA's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .
IKNA moved above its 50-day moving average on July 23, 2025 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IKNA advanced for three days, in of 193 cases, the price rose further within the following month. The odds of a continued upward trend are .
IKNA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 10-day moving average for IKNA crossed bearishly below the 50-day moving average on July 28, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 9 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IKNA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
Industry Biotechnology